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NEW & NOTEWORTHY
The present study found that postischemic myocardial PO2 is a mere reflection of the O 2 supply-demand balance, devoid of a regulatory role, which implies that the intramyocellular O2 gradient is relatively flat in the intact beating heart. Therefore, postischemic PO 2 
not recovering to the preischemic level is not necessarily a predictor of poor prognosis.
ADEQUATE PROTECTION of hypertrophic hearts during cardiac surgery poses an ongoing challenge because the tolerance to ischemia is reduced in pressure-induced left ventricular (LV) hypertrophy (pLVH). Increased inflammatory or oxidative stress, depressed high-energy phosphate (HEP) recovery, and mitochondrial dysfunction have been identified as contributing factors (29, 45, 58) . In addition, there have been reports that reperfused pLVH hearts are prone to develop reflow abnormalities (4, 56, 59) .
One of the reports on reflow abnormalities came from a 31 P NMR study (59) of the spontaneously hypertensive rat (SHR), a genetic rodent model of chronic hypertension. In this study, investigators used pH-sensitive P i resonance as the "real-time" monitor of reflow and observed two distinct P i signals representing two different pH values during reperfusion: one pH value reflecting a swift recovery to the preischemic level and the other pH value representing the prolongation of acidosis. Demonstrating the correlation between the extent of persistent acidosis indicated by the postischemic acidic P i signal (AP) and regional flow as assessed by dye injection, the investigators proposed using the 31 P NMR AP signal as a noninvasive biomarker of no reflow (59) . Since reflow irregularities will impair O 2 return to the heart, our previous observation in the reperfused SHR heart of decreased tissue PO 2 (15) is thus consistent with the impaired reflow in pLVH.
Yet, the paths leading to tissue hypoxia are twofold: decreased O 2 supply or increased O 2 demand (23) . Coronary flow generally matches the metabolic demands of cardiomyocytes (57) . However, after an ischemic episode, a so-called "functional ischemia" (43) can result if cellular O 2 demand is increased to repair ischemic damage (e.g., restoring ion homeostasis) or due to metabolic inefficiency (e.g., mitochondrial uncoupling). Vascular flow, even when it is restored to the preischemic level or higher, may fail to meet the increased O 2 demand, culminating in a tissue O 2 deficit (43) .
Postischemic hypooxygenation in the SHR heart can thus be the consequence of either decreased (vascular) O 2 supply or increased (cellular) O 2 demand or both. Ischemic challenge disrupts cellular ion homeostasis. In this context, it is noteworthy that several studies have reported that the ischemia-induced ion imbalance is increased in pLVH hearts. For example, Na ϩ accumulation is intensified in ischemic SHR hearts (26) . Increased Ca 2ϩ overload has been reported in reperfused pLVH hearts (2) . Since Na ϩ -K ϩ -ATPase and sarco(endo)plasmic reticulum Ca 2ϩ ATPase activities require energy expenditure, it seems reasonable to postulate that the O 2 requirement of the postischemic pLVH heart is increased, thus leading to a tissue O 2 deficit; thus, less O 2 will be available for HEP resynthesis and contractile function.
While reports on reflow abnormalities in the pLVH heart abound, it is currently unknown whether the O 2 demand of the reperfused pLVH heart is altered from that of the normal heart and potentially contributes to hypooxygenation. If it does, to what extent is the postischemic PO 2 deficit caused by the altered O 2 demand and to what extent is it caused by an impaired vascular supply? Is the depressed PO 2 the underlying cause of impaired energy/contractile function recovery often observed in pLVH hearts?
While it may seem obvious that lower cellular PO 2 recovery should lead to lower HEP/contractile function, the relationship between PO 2 and HEP may not be as straightforward as it appears, because a detailed profile of PO 2 within cardiomyocyte remains controversial. Isolated cardiomyocyte (33, 60) and intact myocardium studies (61) have suggested the existence of steep intracellular O 2 gradients and an anoxic cellular core in cardiomyocytes surrounded by a normoxic extracellular environment, setting off the notion that restricted intracellular diffusion of O 2 could be a limiting factor in the functioning of high-flux metabolic system such as the myocardium. In that case, any recovery of Ͻ100% restoration of cellular PO 2 will lead to the expansion of the anoxic core and limit mitochon-drial respiration and HEP resynthesis. In other words, the depressed PO 2 will become the cause of depressed mitochondrial respiration.
If, on the other hand, the intracellular O 2 gradient is relatively flat, as has been indicated by other studies (23, 24, 64) , mitochondrial respiration may recover even in the presence of falling PO 2 as cardiomyocytes presumably possess the reserve capacity to increase the O 2 gradient providing the compensatory driving force for O 2 flux. In that case, cellular PO 2 and energetics would hold no causal relationship.
Few studies so far have examined whether a recovery of tissue PO 2 to the preischemic level is a necessary condition for HEP and other myocardial recovery. If a 100% recovery of the tissue O 2 level is not a prerequisite, then what is the minimum threshold PO 2 required for HEP/contractility recovery and what does it say about the intracellular O 2 gradient structure of the postischemic myocardium? Does the threshold differ between the pLVH heart and the normotensive heart?
In the present study, perfused isolated hypertensive (SHR) and normotensive rat hearts were subjected to ischemia-reperfusion. Another set of normotensive rat hearts was perfused at varying degrees of low flow as a reference to compare with hearts subjected to I/R. 31 
METHODS
Heart perfusion and NMR. The heart perfusion and NMR methods have been previously described in detail (15) . Briefly, isolated hearts were perfused with Krebs-Henseleit buffer equilibrated with 95% O 2-5% CO2, which was warmed to 36°C and contained (in mM) 118 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.8 CaCl2, 1.2 MgSO4, 20 NaHCO3, and 15 glucose. A latex balloon inserted in the LV monitored LV pressure and heart rate via a transducer connected to an oscillographic recorder (Gould Windograf). The rate-pressure product (RPP), an index of the heart's mechanical function, was calculated by multiplying heart rate by LV developed pressure.
Male SHRs (7-9 mo old) were purchased from Taconic Farms (Germantown, NY). Age-matched Wistar-Kyoto (WKY) rats were the controls. Animals were maintained in a facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care. The care and experimental procedures were in accordance with and approved by the Institutional Animal Care and Use Committee of the University of California (Davis, CA).
All NMR recordings used a vertical bore 400-MHz spectrometer (Bruker AMX). The isolated heart was placed in a 20 mm NMR tube and maintained at 36°C with warm air provided by the variable temperature unit in the magnet. A 1-3-3-1 binomial pulse suppressed the H 2O peak and selectively excited oxymyoglobin (MbO2) Val-E11 (␥-CH3) resonance at Ϫ2.8 ppm. MbO2 acquisition was optimized with a 45°pulse angle, 40-ms acquisition time, and 8,065-Hz spectral width. Six thousand transients were averaged for a typical 1 H spectrum, requiring 5 min of signal accumulation. The MbO2 signal was referenced to the H2O peak at 4.67 ppm at 36°C, which was, in turn, calibrated against sodium 3-trimethylsilyl propionate-2,2,3,3-d4 (TSP). 31 P NMR spectra were acquired using a 60°pulse angle and 2-s repetition time (90°pulse angle and 20-s repetition time for fully relaxed spectra). The perfusate lactate concentration was determined in triplicate by a lactate oxidase method (YSI 2700 Bioanalyzer). Myoglobin (Mb) leakage from the heart was assessed by scanning the perfusate sample at 410 -420 nm (5) . Creatine kinase activity in the perfusate was measured by a spectrophotometric enzyme assay (25) . For creatine kinase and Mb, total leakage was calculated by integrating the measured concentration over the time periods of interest. After the perfusion-NMR experiments, hearts were dried at 80°C for 72 h and weighed.
Experimental protocols. During 20 min of baseline perfusion, all SHR (hypertrophic) and WKY (nonhypertrophic) hearts were perfused at constant pressure (CP; 100-mmHg head pressure), and coronary flow was measured by collecting the effluent. Subsequently, hearts were subjected to normothermic zero-flow global ischemia for 19 min followed by reperfusion at 100 mmHg in a subset of hearts. Another subset of hearts was reperfused in the constant flow (CF) mode at each heart's own preischemic flow rate (11.5-13.9 ml·min Ϫ1 ·g heart Ϫ1 ) to induce 100% recovery of global flow. Two repetitions of interleaved 1 H (5 min)/ 31 P (5 min) spectra recorded the basal metabolism for 20 min during preischemic perfusion. During ischemia and the first 15 min of reperfusion, 31 P spectra were acquired every 2.5 min, yielding 14 consecutive 31 P spectra. After 15 min of reperfusion, interleaved 1 H (5 min)/ 31 P (5 min) spectra were recorded for another 20 min.
In the control low-flow experiments (n ϭ 6, Sprague-Dawley rats, 8 -9 mo old), hearts were perfused in the CF mode throughout the experiment. The use of the Sprague-Dawley strain as the control for SHR myocardial studies (in some cases, preferred over the WKY strain) has been previously reported (14, 47) . Before the perfusion experiment, heart weight was estimated from rat body weight. After baseline perfusion at 13-17 ml·min Ϫ1 ·g heart Ϫ1 , inflow rates were decreased to 12 ml·min Ϫ1 ·g heart Ϫ1 for 20 min and then to one more flow step at 2-10 ml·min Ϫ1 ·g heart Ϫ1 for 20 -30 min. (Flow rates used to generate Fig. 5 were in ml·min Ϫ1 ·g heart Ϫ1 based on the actual heart weight measured after the perfusion-NMR experiment and not the heart weight estimated before the perfusion experiment.) Thereafter, the flow rate was reverted to the baseline level to confirm viability of the heart. No control low-flow hearts were subjected to zero-flow ischemia. Although the low-flow condition is in a sense a low-flow ischemia, in the present report the term "ischemia" (appearing as is or appearing in preischemic, postischemic, etc) refers only to zero-flow ischemia.
Myocardial PO 2. O2-ligated Mb (MbO2) in the heart gives rise to distinct 1 H NMR signals that allow measurements of intracellular PO2 (42) . Fractional Mb oxygenation was determined from the area of the MbO2 peak using the following equation:
(1) and intracellular PO2 was calculated from the following relation:
where (PO2)50 (3.8 mmHg) is the O2 pressure required to half-saturate Mb (5) . Based on the retrofitting procedure previously described in detail (15) , the fraction of baseline MbO2 was determined to be ϳ75% of total Mb in both SHRs and WKY rats, yielding a calculated PO2 of 11.7 Ϯ 3.2 mmHg (WKY rats) and 10.5 Ϯ 3.8 mmHg (SHRs) (errors for baseline PO2 were estimated by the propagation of error method; see Error analysis). The baseline PO2 values in SHR and WKY hearts are thus consistent with rodent heart PO2 values measured by other investigators (6 -10 mmHg) (7, 55, 62, 68 ).
Yet, a wide range of mammalian sarcoplasmic PO2 exists in the literature, from ϳ3 to ϳ200 mmHg. Using optical reflectance spectroscopy, Arai and coworkers (6) measured Ͼ90% MbO2 saturation in the in vivo pig heart. Chen and coworkers (8, 13) also reported Ͼ90% MbO 2 saturation (corresponding to PO2 Ͼ 20 mmHg) based on the lack of the 1 H NMR deoxy-Mb signal in the in situ dog heart. Another study (48) measured mitochondrial PO 2 (ϳ35 mmHg) directly from the intact rat heart using O 2-dependent quenching of delayed fluorescence emitted from endogenous protoporphyrin. On the lower end of the spectrum, 8 -10 mmHg in in vivo mouse hearts (68) and 3-10 mmHg in frozen sections of in situ mammalian hearts have been reported (23, 65) .
In the case of ex vivo buffer-perfused heart preparations, optical reflectance studies have reported 6.3 mmHg in guinea pigs (55) and ϳ6 mmHg in rats (7) (calculated from ϳ72% and ϳ70% MbO2 saturation at 37°C, respectively), whereas an electron paramagnetic resonance oximetry study (21) reported ϳ198 mmHg in rat hearts. As such, there appears no easily recognizable pattern in myocardial PO2 levels along the spectrum of in vivo versus ex vivo or invasive manipulations (such as tissue freezing) versus intact functioning hearts.
The wide-ranging variability may partly stem from disparate animal species as well as detection methodologies. NMR detects the whole heart, electron paramagnetic resonance measures localized areas where the crystals are imbedded, and optical spectroscopy measures primarily the epicardial layer due to its shallow penetration depth (ϳ180 -600 m) (6, 55) .
In addition, optical and NMR measurements of Mb are characterized by inherent uncertainty in establishing 100% and 0% O2 saturation points because of surface O2 diffusion, collateral circulations (6) , and the lacking response of percent MbO 2 to adenosine-induced maximal vasodilation (7) . As such, a nonchanging Mb signal in a high-O2 environment does not provide a strong assurance for nonchanging PO2 because the Mb signal intensity can remain more or less the same while PO 2 continues to increase as Mb-O2 binding approaches saturation (see Limitations for further details). The present study therefore determined percent MbO2 by retrofitting the response of MbO 2 to graded hypoxia into a rectangular hyperbolic function (previously described in detail in Ref. 15 ) to indirectly extract the value of normoxic percent MbO2 while avoiding erroneous end-point calibration.
As stated above, a previous optical study (55) reported ϳ72% MbO2 saturation in the perfused guinea pig heart, a result very similar to the present study (ϳ75%). While calculating PO 2 from 72% MbO2 yielded a PO2 value of 6.3 mmHg (55), subsequent mathematical modeling using the same data led to an average myocardial PO 2 value of ϳ223 mmHg (10). The Ͼ35-fold higher PO 2 was the outcome of the model's prediction that myocardial O 2 distribution is skewed toward two extremes: one myocyte population with high MbO 2 saturation and another group of myocytes experiencing relatively severe hypoxia.
Due to the nonlinear Mb-O2 binding curve, PO2 calculated from tissue-average percent MbO 2 can differ significantly from PO2 calculated by averaging an individual myocyte's PO 2. For example, if there are two myocyte populations in equal number, one myocyte population with 99% MbO2 saturation and the other myocyte population with 51% MbO 2 saturation, then the average MbO2 saturation is 75%. Converting 75% MbO 2 to PO2 gives 11.4 mmHg [if 3.8 mmHg is used as ( PO 2)50]. Yet if 99% and 51% MbO2 are separately converted to PO 2 values (376 and 3.96 mmHg, respectively) and then averaged, the result will be 190 mmHg.
Frozen tissue measurements (23) showed relatively uniform PO 2 distribution across the subepicardium as well as along the length of the capillary. If myocardial PO 2 distribution is as uniform as reported by these studies, calculating average PO2 directly from average percent MbO2 may be justified. As the present study did not embark on a mathematical modeling designed to predict the pattern of heterogeneous PO2 distribution, I will simply present the PO2 values converted directly from measured percent MbO2 as most other studies have done so (6, 7, 13, 23, 55, 65). However, given the possibility of substantial PO2 heterogeneity, the tissue-average PO2 reported in the present study can be an underestimation (or even an overestimation) of true average PO 2.
Capillary perfusion. Because Mb is equally NMR visible regardless of its location within the myocardium, the 1 H NMR method reports the tissue-average Mb from the whole heart in contrast to Doppler or optical imaging methods, which detect signals primarily from the epicardial layer (6, 7, 55) . Provided that the information on MV O2 and capillary PO2 are available, the density of perfused capillaries can be estimated from myocardial PO 2 using O2 diffusion models (21) . It is then expected that the percent perfused capillary thus estimated should agree with the 31 P NMR assessment of no reflow. Therefore, 1 H NMR, combined with 31 P NMR detection of AP signals, can potentially offer an opportunity to examine the degree to which microvascular abnormalities contribute to postischemic PO 2 depression.
The density of perfused capillary was estimated by adapting Krogh's O 2 diffusion model to represent microvascular perfusion, as follows:
where px is intracellular PO2 (measured from the Mb signal), po is capillary PO 2 [calculated from arterial and venous PO2 (35)], m is MV O2 of the heart, d is the tissue O2 diffusion constant, R is one-half of the intercapillary distance, x is the distance from a given intracellular point to the nearest capillary midpoint, and r is the radius of the capillary. The values of d and r were taken from literature-reported values for the rodent heart, and, for simplification of calculation, x and R were assumed to be identical (21, 57) . The inverse of the square of mean intercapillary distance (1/4R 2 ) reflects the density of open capillaries (21) . Postischemic capillary density, termed "capillary reperfusion" in this report, was expressed as a percentage of the preischemic capillary density of each heart.
Phosphate metabolite analysis. Quantification of 31 P NMR signals [phosphocreatine (CrP), P i, and ␤-nucleoside triphosphate] in absolute concentration (in mM) has been previously described in detail (15) . Briefly, the LV balloon was filled with 100 mM phenylphosphonate. After collection of baseline 31 P spectra, the balloon was inflated by 0.04 ml, which corresponds to 4 mol of the phenylphosphonate signal. The change in phenylphosphonate signal intensity was then considered to represent 4 mol of 31 P nuclei and used to calibrate other 31 P signals in fully relaxed spectra. A fully relaxed spectrum was obtained only in the beginning of the experiment, followed by partially saturated spectra. Assuming that no significant changes in the longitudinal relaxation time occur as a result of ischemia (46) , the same longitudinal relaxation time correction factor was applied for partially saturated spectra obtained during preischemic, ischemic, and postischemic periods.
Intracellular pH (pHi) was evaluated from the Pi peak chemical shift using the following relation:
where pK equals 6.9, ␦A is ␦ppm (chemical shift) of H2PO 4 Ϫ at 3.290 ppm, ␦B is ␦ppm of HPO 4 2Ϫ at 5.805 ppm, and ␦o is ␦ppm of observed Pi. Ischemic and postischemic Pi resonances are often composite peaks and, therefore, asymmetric. Consequently, the median point of the integrated Pi peak, as opposed to the highest point of the peak, was used to determine pHi.
The postischemic AP signal was defined in this study as the postischemic Pi resonance reflecting pHi no more than 0.2 pH units alkaline compared with the end-ischemic pHi of each heart. When the AP signal was present in the spectrum, a weighted average ␦ppm of the AP and the main Pi signal (reflecting recovered pHi) was used to calculate overall myocardial pHi (see Fig. 3C ).
Error analysis. Data are presented as means Ϯ SE. Statistical significance was determined by a standard Student's t-test (P Ͻ 0.05). Errors for the computed values were estimated by the propagation of error method based on partial differential calculus.
RESULTS

Anatomy and physiology.
The LV-to-body weight ratio of the SHR heart was ϳ45% larger than that of the WKY heart, indicating moderate hypertrophy (Table 1) . WKY rats are typically larger than SHRs for the same age group. To rule out the possibility that the larger body size of WKY rats contributed to the underestimation of the LV-to-body weight ratio, data from only the comparable weight ranges of SHR and WKY rats (n ϭ 15 total rats, 400-to 500-g range) were also analyzed, which showed an ϳ34% increase in SHRs (P Ͻ 0.00001). There were no changes in the right ventricle-to-body weight ratio and no signs of hepatomegaly and pleural effusion, indicating the absence of heart failure.
Baseline RPPs (an index of mechanical function of the heart) were 21,160 Ϯ 1,557 and 28,310 Ϯ 2,062 beats·min Ϫ1 ·mmHg in WKY rats and SHRs, respectively. CrP levels were 28.2 Ϯ 0.8 and 32.0 Ϯ 0.5 mol/g dry heart in WKY rats and SHR, respectively. Both RPP and CrP levels were significantly higher in SHR hearts (P Ͻ 0.05), showing the characteristic signs of (super)compensated hypertrophy (11, 36) . MV O 2 in the SHR group, on the other hand, was not different from the WKY group (25.7 Ϯ 2.0 mol·min Ϫ1 ·g Ϫ1 dry heart in the WKY group and 27.6 Ϯ 1.1 mol·min Ϫ1 ·g Ϫ1 dry heart in the SHR group, P Ͼ 0.05).
Ischemia. Upon stop of arterial flow, LV developed pressure declined rapidly. At ϳ4 min from the ischemic onset, contractile activity was no longer detected (Fig. 1A) . At ϳ7 min, hearts began to develop ischemic contracture, which reached the peak at ϳ16 min of ischemia (Fig. 1B) . SHR hearts developed significantly higher peak contracture pressure (ϳ68 -81 mmHg in SHR hearts vs. ϳ53 mmHg in WKY hearts, P Ͻ 0.05).
As expected, zero-flow ischemia induced a rapid decline in CrP and increase in P i (Figs. 2 and 3A) . CrP decreased significantly more rapidly in SHR hearts (P Ͻ 0.001); during the first 1.3 min of ischemia, CrP decreased by 24 Ϯ 0.8 mol in SHR hearts and 19 Ϯ 0.2 mol in WKY hearts. By 3.8 min, CrP was depleted in SHR hearts, whereas a residual amount of CrP (ϳ14% of the preischemic level) was still present in WKY hearts (Fig. 3A) . The ATP concentration, buffered by CrP hydrolysis, decreased at a slower pace than CrP (Fig. 3B) . The rate of ATP decline was not significantly different in SHR and WKY hearts. Immediately after the onset of ischemia, the rate of acidification in SHR hearts was the same as in WKY hearts (Fig. 3C) . Starting from the second time point (3.8 min), however, the decline in pH i began to slow down in WKY hearts, whereas it remained significantly faster in SHR hearts. Consequently, ischemic acidosis was exacerbated in SHR hearts.
Although MbO 2 data were not collected in the present study during ischemia and early reperfusion (Fig. 3D) , our previous 1 H time course study (15) showed that MbO 2 signals are no longer detected within Ͻ2.5 min of ischemia, i.e., PO 2 drops to ϳ0 mmHg, in both SHRs and WKY rats. A period of ventricular fibrillation and sporadic bouts of tachyarrhythmia (typically ϳ10 min) followed the onset of reflow until normal sinus rhythm contractions resumed. Afterward, RPP continued to increase until it reached the steady level at ϳ30 min of reperfusion (Fig. 1A) . In all hearts, the final recovered RPP level was in proportion with MV O 2 recovery, leaving the aerobic efficiency, RPP/MV O 2 , unchanged from the preischemic ratio (Fig. 1C) .
The present study found transient or persistent AP signals in a subpopulation of reperfused SHR hearts, a finding similar to previous reports (11, 59) . The definition of persistent versus transient is somewhat arbitrary: persistent AP signals were defined as AP signals that were continuously detected throughout the entire reperfusion (35 min). Transient AP (tAP) signals were detected only during the first ϳ10 min of reperfusion.
More than half of CF-reperfused SHR hearts (7 of 11 SHR hearts) showed tAP signals during early reperfusion (SHRtAP; Figs. 1, 3, and 4) . The remaining four CF-reperfused SHR hearts did not show any AP signals (SHR-nAP). In contrast, in 5 of 10 CP-reperfused SHR hearts, AP signals persisted throughout the entire reperfusion period (persistent AP). Four CP-reperfused SHR hearts developed tAP signals, and one CP-reperfused SHR heart did not develop any AP signal. No AP signals, transient or persistent, were detected in WKY hearts, except for one CP-reperfused WKY heart.
When CF-reperfused SHR hearts were classified into two groups, i.e., SHR-tAP and SHR-nAP, it became clear that the difference from normotensive WKY hearts was more prominent in SHR-tAP hearts, whereas metabolic and physiological responses of SHR-nAP hearts fell on an intermediate level between SHR-tAP and WKY hearts (Figs. 1 and 3 ). For example, the final recovered levels of CrP, MV O 2 , PO 2 , and RPP were in ascending order from SHR-tAP to SHR-nAP to WKY hearts, although HEP and MV O 2 initially recovered rapidly in all three groups of hearts (Figs. 1 and 3) . CrP recovered to ϳ104% of the preischemic level in WKY hearts, accompanied by a characteristic early reperfusion overshoot (ϳ10%) (20, 39) . In SHR-nAP and SHR-tAP hearts, CrP recovered to 90% (P Ͼ 0.05 vs. WKY hearts) and 59% (P Ͻ 0.001 vs. WKY hearts) of the preischemic level, respectively (Fig. 3A) .
ATP recovered to ϳ34% of the preischemic level in SHRtAP hearts and ϳ40% in WKY/SHR-nAP hearts (P Ͼ 0.05, SHR-tAP vs. WKY hearts; Fig. 3B ). It is well documented that ATP content in the reperfused heart remains depressed for hours even when aerobic ATP synthesis is fully restored because adenine, a breakdown product of ATP, diffuses to the extracellular space during ischemia and is washed away upon reperfusion, reducing the size of intracellular adenine nucleotide pool (20, 39) . Figure 3C shows that the severity of end-ischemic acidosis was also in ascending order, WKY (pH i 6.25 Ϯ 0.07), SHRnAP (pH i 6.01 Ϯ 0.05), and SHR-tAP (pH i 5.83 Ϯ 0.02), in which SHR-tAP pH i was significantly lower than that of WKY pH i (P Ͻ 0.01), whereas SHR-nAP pH i was not significantly different from WKY pH i . Although the recovery of the main P i signal (which reflects recovered pH i ) in SHR-tAP hearts was as rapid as in SHR-nAP or WKY hearts (Fig. 4), Fig. 3C shows a delayed SHR-tAP pH i recovery as it shows the whole heart pH i derived from the weighted average ␦ ppm of AP and the main P i signal.
Similar to CrP, postischemic MV O 2 and PO 2 in SHR-tAP hearts were significantly depressed compared with WKY hearts (P Ͻ 0.05) but not in SHR-nAP hearts (P Ͼ 0.05, SHR-nAP vs. WKY hearts; Fig. 3D ). Due to the sensitivity limitation of NMR measurements, early reperfusion time course data were collected for either 31 P or 1 H, but not both in the same heart. As a result, Fig. 3D shows late reperfusion 1 H data (PO 2 ); the connecting lines to early reperfusion are inferences based on our previous 1 H time course experiments (15), which showed that postischemic PO 2 reaches a steady level at least by 1.3 min of reperfusion. Although the present 31 P time-course experiments and the previous 1 H time-course experiments were acquired from different groups of hearts, they are parallel sets of experiments (i.e., identical ischemia-reperfusion protocol using the same animal models) except that the 31 P NMR spectra (SHR-tAP heart). Spectrum A was acquired immediately after reperfusion. Extracellular pH initially recovered to ϳ7.28 (with some pH dispersion). By the third spectrum (spectrum C), which corresponds to 7.5 min from the start of reperfusion, the extracellular Pi peak sharpened and showed a complete recovery to an extracellular pH of 7. Fig. 1 shows a representative preischemic spectrum.) previous experiments followed the 1 H time course instead of the 31 P time course. Disparate responses to ischemic challenge in SHR subpopulations, as observed in the present study, have been previously reported. Golden and colleagues (26) reported increased Na ϩ accumulation in ischemic SHR hearts, which correlated with delayed functional recovery. Yet, they noted a subpopulation of SHR hearts unchanged from WKY hearts. Although most of the parameters measured in the present study were nominally depressed in SHR-nAP hearts compared with WKY hearts, none of the differences between SHR-nAP and WKY hearts reached statistical significance. As such, SHR-nAP hearts behaved almost like WKY hearts, whereas SHR-tAP hearts grossly underperformed, indicating that AP signals, even when they appear only briefly, can predict a poor prognosis in the reperfused heart.
Flow recovery. Global coronary flow of CP-reperfused hearts recovered to ϳ72% and ϳ78% of preischemic flow in SHR and WKY hearts, respectively (P Ͼ 0.05, SHR vs. WKY hearts; Fig. 5 ). On the other hand, percent capillary reperfusion estimated by Krogh's O 2 diffusion model (see METHODS) was ϳ58% and ϳ90% of the preischemic level in SHR and WKY hearts, respectively (P Ͻ 0.05). To distinguish microvascular perfusion from global flow, in a subsequent set of experiments, hearts were reperfused in the CF mode, which normalized global flow to 100% of the preischemic level in all hearts. CF reperfusion improved capillary reperfusion in both SHR and WKY hearts (Fig. 5 ). Yet despite 100% global flow recovery, capillary reperfusion of SHR hearts was still depressed compared with WKY hearts (82% vs. 116%, P Ͻ 0.05). Thus, independent of global flow recovery, SHR microvascular reperfusion was depressed by 32-34% compared with WKY microvascular reperfusion. Finally, whereas no CF-reperfused SHR hearts showed persistent AP signals, 50% of CP-reperfused SHR hearts did (Figs. 6 and 7) .
The degree of tissue edema, as indicated by the wet-to-dry heart weight ratio, was similar between WKY and SHR hearts (P Ͼ 0.05; Table 1 ) and was also similar between CP-and CF-reperfused hearts (P Ͼ 0.05; data not shown; Table 1 shows combined CP/CF data). This indicates that CF reperfusion, despite its propensity to increase perfusion pressure, did not exacerbate tissue edema.
DISCUSSION
Global-microvascular flow mismatch in SHRs.
Capillary reperfusion of the SHR heart was significantly depressed compared with WKY or control hearts at given global flow rates, presenting a clear example of redistribution of total flow and suggesting that a substantial portion of global flow was shunted away from the microvascular network in SHRs (Fig. 5) . The microvascular reperfusion deficit observed in SHRs is likely to originate from functional and structural alterations in the coronary vasculature reported in pLVH, which include a reduced coronary reserve, luminal narrowing of microvessels, a reduction of hyperemic responses, and microvessel compression due to increased diastolic pressure (12) . Indeed, in the present study, the role of diastolic pressure seems paramount; the CF-induced increase in capillary reperfusion in the SHR heart correlated closely with improved myocardial relaxation (Fig. 7B) .
According to the vascular waterfall hypothesis, when the microvessels partially collapse and intramyocardial pressure exceeds venous pressure, the driving pressure for flow is not the arteriovenous pressure difference but arterial pressure minus intravascular pressure at the collapse point (30) . LV end-diastolic pressure of postischemic SHR hearts was markedly increased over WKY hearts (Figs. 1B and 7, A and B) , which implies that the effective (waterfall) perfusion pressure must have been decreased in SHRs, contributing to lower capillary reperfusion.
While it is well accepted that incidences of subendocardial no reflow are increased in pLVH hearts, some studies have shown that the recovery of total flow is also depressed in the postischemic pLVH myocardium (28, 56) . Yet, it is unclear whether inducing a recovery of global flow will necessarily lead to a proportionate improvement in microvascular perfusion because vascular resistance at various levels of the microvasculature can be redistributed during ischemic stress and the pressure increase accompanying the augmentation of flow can paradoxically provoke autoregulatory vasoconstriction via myogenic mechanisms (17, 52) . The potential opposing effect of the myogenic response would be especially germane to pLVH hearts as pathological increases in myogenic vasoconstriction have been documented in hypertension (34) .
In the intact heart, flow-induced vasodilation is mediated by interactions of various mechanisms, including passive dilation of arteries, an increase in MV O 2 and consequent metabolic vasodilation, or activation of shear stress-sensitive receptors of the vascular endothelium (17, 32) . While it would be difficult to clearly delineate the individual mechanism in an intact heart study (32) , it is still possible to examine whether augmenting global flow and flow-induced vasodilation, regardless of its mechanism, can improve microvascular reperfusion of the pLVH heart. Figure 5 shows that capillary reperfusion increased in response to CF reperfusion (i.e., inducing 100% recovery in global flow) without exacerbating tissue edema in both SHRs and WKY rats (see the account on tissue edema in the RESULTS). This implies that flow-induced vasodilation remained intact and prevailed over myogenic constriction in both SHRs and WKY rats despite the general notion that coronary flow should autoregulate at Ͼ80 -100 mmHg (11) . Control low-flow data indeed agree with the expectations of autoregulation; capillary perfusion of control hearts reached a plateau at ϳ12 ml/min of global flow, which corresponds to ϳ85-mmHg perfusion pressure, and a further increase in flow (and accompanying increase in pressure) did not increase capillary perfusion (Fig. 5) . The seemingly extended flow response of reperfused SHR and WKY hearts may originate from the metabolic and vascular conditions peculiar to postischemic hearts, which include increased extracellular adenosine and increased activity of endothelium-dependent shear stress mechanotransduction (32, 40) .
To what degree the improvement induced by CF reperfusion in SHRs was due to flow-induced vasodilation or due to increased waterfall pressure is difficult to discern from the present study. It is likely that these two factors interacted to form a positive feedback loop: flow-induced vasodilation initiates an increase in tissue perfusion and HEP recovery, which, in turn, reduces diastolic dysfunction and raising the waterfall pressure, which further improves microvascular perfusion. While the underlying mechanism remains obscure, the present results imply a potential clinical utility of artificially augmenting flow when resuscitating pLVH hearts, especially pLVH hearts with diastolic dysfunction. (Figs. 6A and 7B ). The cellular PO 2 level, in turn, correlates with these flow parameters (Fig. 6A) , consistent with the scenario that an impaired vascular supply limits PO 2 recovery in SHRs. However, Fig. 6A also shows clearly that PO 2 values in postischemic hearts are significantly lower than PO 2 values in control low-flow hearts receiving the same amount of capillary perfusion. Considering that flow is the only experimental parameter that was manipulated, therefore assuming that flow must be the major determinant of PO 2 in control hearts, the additional PO 2 decrease observed in reperfused SHR and WKY hearts should then arise from factors other than flow limitation.
Analysis of flow versus nonflow components of PO 2 depression showed that only the nonflow mechanism contributed to postischemic hypoxia in CF-reperfused WKY hearts (Fig. 6B) . This is not surprising because CF-reperfused WKY hearts were not flow limited, in terms of both global flow and capillary reperfusion (Fig. 5) . What was unexpected was the depth of hypoxia in CF-reperfused WKY hearts (Figs. 3D and 6A) , which otherwise showed a full recovery in flow, energy (HEP), and function (RPP). In SHR hearts, on the other hand, the microvascular flow limitation plays more dominant role, and the relative contribution of flow (relative to nonflow mechanism) linearly increases as reflow abnormalities become more severe (Fig. 6B) . Therefore, although the nonflow mechanism does contribute significantly to the PO 2 depression in SHRs, the exacerbated tissue hypoxia (compared with WKY rats) is caused mainly by flow limitation, contradicting the initial hypothesis that abnormally increased O 2 demand exacerbates postischemic hypoxia in SHRs. The relative hypoxia of the postischemic heart is consequently expressed as the increased MV O 2 -to-PO 2 ratio (Fig.  6C) ; postischemic MV O 2 in both SHR and WKY hearts was significantly increased from MV O 2 in control hearts at a given PO 2 . Because of Ͻ100% capillary flow recovery, the absolute quantities of postischemic MV O 2 are lower than the preischemic level in all heart groups except CF-reperfused WKY hearts. The increased MV O 2 -to-PO 2 ratio, however, is an indication that MV O 2 exceeds vascular O 2 supply and results in an O 2 supply-demand imbalance. Plotting the flow-independent PO 2 depression versus MV O 2 increase (over control low-flow hearts) reveals that, indeed, almost all of the flow-independent PO 2 depression can be explained by increased V O 2 (note the regression line intersecting the origin, Fig. 6D ). The implication of this observation becomes clear: the postulated causeand-effect relationship (low PO 2 recovery ¡ low mitochondrial respiration) does not hold in the postischemic hearts examined in the present study. Instead, the data support the converse: increased respiration causes lower PO 2 .
Role of PO 2 in myocardial recovery. The overshoot in capillary reperfusion in the postischemic WKY heart (Figs. 5 and 7B) is reminiscent of reactive hyperemia and paradoxically increased V O 2 frequently observed in reversible ischemiareperfusion models (18) . Consistent with the minimal irreversible ischemic damage, the cardiac parameters of CF-reperfused WKY hearts [MV O 2 , contractile function (RPP), and CrP] fully recovered. Yet, cellular PO 2 did not recover to the preischemic level even in CF-reperfused WKY hearts (Figs. 3D and 6A) . It is unlikely that the MV O 2 -PO 2 mismatch in CF-reperfused WKY hearts is the result of local regions of focal ischemia interspersed with regions experiencing unusually high V O 2 , possibly caused by locally increased O 2 demand or wasteful V O 2 via mitochondrial uncoupling. In that case, not only the cellular PO 2 but also HEP would have failed to recover fully, which was not the case.
The MV O 2 and CrP in WKY rats that recovered Ͼ100% in the presence of depressed PO 2 recovery demonstrates that myocardial oxidative metabolism can operate at full capacity without repaying the O 2 debt incurred during ischemia. Although most emphatically demonstrated in CF-reperfused WKY hearts, the increased MV O 2 -to-PO 2 ratios (compared with control hearts) were observed in all postischemic hearts, indicating that postischemic mitochondrial respiration is not limited by intracellular O 2 availability, at least when cellular PO 2 is Ͼ1.9 mmHg (Fig. 6C ). As such, the present data cast postischemic myocardial PO 2 as a passive reflection of the balance between O 2 supply and demand, not the regulator of oxidative phosphorylation. In fact, the lower cellular PO 2 of the postischemic heart might be an advantage as it can facilitate O 2 extraction.
This indicates that extra-or intracellular signaling(s) other than O 2 (e.g., Ca 2ϩ , phosphorylation potential, the NADH-to-NAD ratio, etc.) are involved in raising postischemic MV O 2 above the preischemic level (CF-reperfused WKY hearts) or above low-flow control hearts (all heart groups). Since the K m,O 2 value of cytochrome oxidase is extremely low (ϳ0.1 mmHg) (61) , it may indeed be "O 2 flux," not sarcoplasmic "O 2 concentration," that renders a limiting condition for cellular respiration in the myocardium.
As a result, the present data imply that the intracellular O 2 gradient may not be as steep as previously postulated (33, 60, 61) . Even at ϳ1.9-mmHg PO 2 (the intracellular O 2 gradient, if it exists, must be very shallow at this level of PO 2 ), postischemic myocytes were able to muster an extra O 2 flux beyond the level achieved by control hearts (ϳ160% increase; Fig. 6C ). Although observed specifically in reperfused SHR and WKY hearts, the apparent variability in the MV O 2 -PO 2 relationship suggests a more generalized phenomenon, that is, the resistance to intracellular O 2 transport appears to be low and myocardial respiration is not limited by cellular PO 2 , except possibly under severely hypoxic conditions approaching ϳ0.1 ϩ immediately before reperfusion. Among CF-reperfused hearts, LVEDP of SHR-tAP hearts was increased from WKY hearts (P Ͻ 0.05), whereas LVEDP of SHR-nAP hearts was not statistically different from WKY hearts. Among CP-reperfused hearts, both SHR-tAP (P Ͻ 0.05) and SHR-pAP (P Ͻ 0.001) hearts showed significantly increased LVEDP compared with WKY hearts. B: capillary reperfusion versus LVEDP. Capillary reperfusion is expressed as a percentage of preischemic capillary perfusion. mmHg, the level at which MV O 2 will eventually be restrained by a diminishing perimitochondrial O 2 gradient.
These signs of a relatively flat intracellular O 2 gradient in the contracting myocardium are similar to the findings of nearuniform O 2 distribution in isolated cardiac and skeletal myocytes (23, 24, 64) and the low critical PO 2 for maximal V O 2 (ϳ0.5 mmHg) reported in frozen canine gracilis muscles (24) . Indeed, given the postulated role of Mb's facilitated diffusion of O 2 in red muscle, O 2 flux in the heart could be maximized when intracellular PO 2 is relatively low, i.e., within the functional range of the Mb-O 2 dissociation curve (31, 66) . The conclusions reached by previous investigations using isolated myocytes, isolated mitochondria, and mathematical deductions (16, 23, 24, 31, 66) , that cellular respiration is likely to be insensitive to PO 2 within a wide range of PO 2 values, seems to be valid in the adequately reperfused as well as flow-limited postischemic myocardium.
Ischemic acidosis and diastolic dysfunction. Ischemic acidosis was exacerbated in SHR hearts, especially those that showed transient or persistant AP signals during reperfusion (Figs. 3C and 7A ). The increased ischemic acidosis in SHR hearts has also been observed by other investigators (59) and is likely to originate from increased myocardial glycogen content and/or metabolic alterations; several animal models of pLVH show a decrease in fatty acid oxidation and a compensatory increase in glycolysis (3, 27) . Increased lactate accumulation during ischemia, as reflected in the first postischemic measurement of the perfusate lactate level (24.8 Ϯ 1.3 mol·min Ϫ1 ·g dry wt Ϫ1 in the SHR-tAP group and 10.5 Ϯ 0.8 mol·min Ϫ1 ·g dry wt Ϫ1 in the WKY group, P Ͻ 0.001), further supports the possibility of increased anaerobic glycolysis in SHRs. The delayed ischemic contracture buildup in the SHR-tAP group (Fig. 1B) is also consistent with increased glycolytic ATP production.
Adverse effects of ischemic acidosis are well documented. Ischemic acidosis can directly injure myocytes via acid activation of lysosomal hydrolases (20) . It can also indirectly induce postischemic dysfunction by exacerbating cytoplasmic Ca 2ϩ overload; H ϩ clearance during reperfusion can lead to a cascade of ion exchanges involving Na ϩ influx via the Na ϩ -H ϩ exchanger with subsequent net flux via reverse-mode Na ϩ -Ca 2ϩ exchanger activity, culminating in Ca 2ϩ influx into myocytes (39, 50) .
One of the detrimental consequences of Ca 2ϩ overload is myocardial stiffness and diastolic dysfunction. Reperfused SHR hearts showed pronounced diastolic dysfunction in proportion to the degree of H ϩ accumulation (Fig. 7A) , consistent with the possibility that increased ischemic acidosis led to postischemic Ca 2ϩ overload. Indeed, a previous study (2) has reported increased postischemic Ca 2ϩ overload in aortic constricted pLVH hearts.
Diastolic dysfunction can also be induced by ATP deficiency via rigor formation (41) . In fact, the cellular Ca 2ϩ concentration and ATP concentration are interrelated because Ca 2ϩ metabolism is partly regulated by ATP-dependent pumps at the sarcoplasmic reticulum and sarcolemmal membrane. Yet, the possibility of a ATP deficit contributing to diastolic dysfunction in the SHR heart seems low. In all heart groups, postischemic ATP recovered to a similar level, whereas the severity of diastolic dysfunction varied widely (Figs. 3B and 7, A and B) .
This leaves ATP-independent Ca 2ϩ overload as the most plausible mechanism. The close correlation among ischemic acidosis, diastolic dysfunction, and capillary reperfusion observed in the present study is intriguing and necessitates a further investigation to establish a causal relationship between the H ϩ -Na ϩ -Ca 2ϩ cascade and reperfusion abnormalities in SHRs. Indeed, this could potentially explain why the contribution of increased O 2 demand (in causing depressed PO 2 recovery) is less prominent in SHRs despite the apparent need for increased energy expenditure. Ion imbalance, while calling for higher O 2 demand, will also impede reflow, which then sets the upper limit on maximum O 2 supply available for the SHR heart despite increased needs.
Limitations. In the present study, insulin was omitted because increased insulin resistance in the heart and skeletal muscle has been reported in SHRs (1, 19) . In the absence of insulin, high glucose in the perfusate facilitates glucose transport as glucose transporter 1 depends mainly on the concentration gradient. However, recent studies have shown that high glucose (Ͼ10 mM) can induce vasoconstriction in isolated arteries and cultured vascular cells (51) . Although previous perfused heart studies that used 15 mM glucose (without insulin) (22) showed no significant differences from hearts perfused with 10 -11 mM glucose (without insulin) (37, 38, 53) in terms of MV O 2 (ϳ37 vs. 29 -35 mol·g dry wt Ϫ1 ·min Ϫ1 in hearts perfused with 15 vs. 10 mM glucose), ATP (ϳ25 vs. 24 -26 mol/g), or the ability to increase the heart's workload (4.2-vs. 3.1-fold increase in RPP when hearts were paced at 600 beat/min with 80 ng/ml dobutamine and end-diastolic pressure raised to 17 vs. 24 mmHg), there remains a concern that glucose-induced vasoconstriction might have influenced the results of the present study. If the relatively high glucose (15 mM) used in the present study predisposed hearts to vasoconstriction, however, there are no indications that the SHR heart was disproportionately affected; preischemic MbO 2 saturation was ϳ75% in both SHR and WKY groups, and SHR hearts showed normal coronary flow and (supra)normal cardiac performance (RPP and HEP) during baseline perfusion.
While fatty acid is a preferred substrate for myocardial metabolism under normoxic conditions in vivo, there have been reports that fatty acid metabolism is compromised in pLVH hearts. Specifically, in SHRs, both fatty acid uptake and metabolism were shown to be depressed (1, 14, 27) . As the present study inquired as to whether exacerbated tissue hypoxia contributes to ischemic susceptibility of the SHR heart, it was deemed that perfusion conditions that will disadvantage SHR metabolism, such as insulin or fatty acid, would complicate data interpretation. In addition, while typically ϳ30% of energy is derived from glucose under normal conditions, the dependence on glucose increases during hypoxia, ischemia, and pressure overload hypertrophy (44) . As the present study focused on ischemic and postischemic hearts, glucose as the sole substrate was considered adequate for the purpose of the study. Nevertheless, a euglycemic substrate mixture (for example, 5 mM glucose with insulin, ϳ1 mM lactate-0.1 mM pyruvate, and Ͻ1 mM fatty acid) would be closer to physiological conditions and, therefore, would be considered as the substrate choice in followup studies.
The sensitivity limit of the 1 H NMR MbO 2 method is estimated to be ϳ0.2 mmHg with 5 min of signal accumulation, which corresponds to ϳ5% of the maximum MbO 2 signal intensity (15, 42) . Because of the nonlinear nature of Mb-O 2 binding, however, the measurement error becomes magnified at high PO 2 . At 90% MbO 2 saturation, a 5% signal detection error leads to an ϳ100% error in the PO 2 calculation (calculating PO 2 from 90% and 95% MbO 2 yields 34-and 72-mmHg PO 2 , respectively). Above Ͼ95% MbO 2 saturation, a 5% error translates to an inability to distinguish PO 2 ranging from 72 mmHg and higher, practically capping the upper limit of the 1 H NMR MbO 2 method to ϳ70 mmHg. The limitation applies to both optical and NMR measurements of Mb. As a result, comparative studies using alternative methods, for example, the porphyrin fluorescence lifetime technique (48, 49) , will be helpful when examining higher PO 2 ranges.
It is known that coronary flow is not uniform across the myocardium and shows temporal fluctuations (9) . Perfusion heterogeneity may increase further in ischemic hearts (54) , as has been corroborated by AP-developing SHR hearts in the present study. While this can complicate the interpretation of data, it will not fundamentally affect the analysis because the perfusion heterogeneity, blood flow/tissue volume, can be correlated one-to-one with V O 2 /tissue volume (63) . As long as the (blood flow-V O 2 -PO 2 ) relationship remains unchanged throughout myocardial volume units (which is a reasonable assumption), the tissue-average measurement should reflect (blood flow-V O 2 -PO 2 ) characteristics of unit volume.
Reactive hyperemia is likely to be more robust in vivo than in perfused hearts as the endothelial function of bufferperfused hearts may be less than optimum (67) . As a result, the O 2 supply-demand imbalance and resultant tissue O 2 deficit may be less pronounced in vivo. However, the robustness of reactive hyperemia should not change the conclusion arising principally from the altered MV O 2 -to-PO 2 ratio and the comparison of postischemic hearts with control low-flow hearts, which remains valid regardless of the absolute value of PO 2 .
Conclusions. The present study found the following: first, in both SHRs and WKY rats, an increased O 2 demand contributes to postischemic hypoxia. However,the further exacerbation of tissue hypoxia in SHRs, compared with WKY rats, arises mainly from microvascular reflow limitation. Second, myocardial PO 2 in the postischemic heart does not regulate oxidative phosphorylation but only passively reflects the O 2 supply-demand balance. While restoration of O 2 flux is crucial for postischemic recovery, PO 2 per se (at least when it exceeds Ͼ1.9 mmHg) does not limit mitochondrial respiration and HEP resynthesis. Apparently, extra-or intracellular signaling other than O 2 elicits the overshoot in V O 2 in the reperfused heart. Third, myocardial oxidative metabolism recovering to preischemic states without fully repaying the O 2 debt contradicts the existence of an anoxic cellular core and a steep intracellular O 2 gradient. The data support a relatively flat intracellular O 2 gradient. Fourth, the ability of the postischemic heart to increase O 2 flux at low cellular PO 2 further suggests that the resistance to intracellular O 2 transport is low. Finally, even a brief appearance of a 31 P NMR AP signal during early reperfusion can predict a prolonged hypoperfusion and poor prognosis of the reperfused heart.
